Deliver logo
Previous Sponsor
Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit
JenKem Technology is dedicated to the development and supply of PEG-based products and custom PEGylation services, with worldwide distribution, and the recent significant addition of new R&D through commercial scale GMP facilities.
Development and manufacture of a wide range of PEG derivatives with high purity and low polydispersity, currently in 1 gram to 40 kg or greater sized batches, under ISO 9001 and ISO 13485 certified Quality Management Systems, following ICH Q7A guidelines and operating under cGMP protocols for regulated customers. Custom synthesis of Y-Shaped PEGs, Methoxy PEGs, Homobifunctional PEGs, Heterobifunctional PEGs, Multi-arm PEGs, Multi-arm Heterobifunctional PEGs, Monodisperse (Discrete) PEGs, Biodegradable PEG Co-Polymers (such as PEG-PLGA, PEG-PLA, PEG-PCL, and other block polymers), and PEG GPC Standards.
Custom PEGylation of proteins, peptides, oligonucleotides, and small molecules; and conjugation of PEGs to other polymer systems. Large scale manufacturing on a custom synthesis basis, which offers the flexibility to match a customer’s specifications.
AnJie Law Firm was founded by a group of senior lawyers committed to providing a high quality of service to international and domestic clients. Our attorneys are highly-regarded advisors with years of legal experience in a wide variety of fields, including insurance, intellectual property, antitrust, private equity, mergers & acquisitions, employment, TMT, capital markets, government policies, general corporate and regulatory matters, and high-stakes litigation and arbitration. Clients consistently give high marks to our services, acknowledging our attorneys’ effectiveness, reliability, and creativity. AnJie has quickly established its reputation as a first tier, elite law firm in China. Since its inception, AnJie Law Firm has been awarded “Rising Firm of the Year” (2013) by Asian Legal Business (ALB), and ranked within ALB’s list of “China’s Fastest 10 Growing Firms”. More recently, AnJie was awarded “Employer of Choice 2016” by ALB, “2016 Employer of Choice Career Outlook China: PRC Firm” by LEGALBAND and “2016 Fast 10 Growing Law Firms in China”, again by ALB. In addition, AnJie has been recognized both as a “Recommended Leading Firm”, and “Firm of the Year” in major practice areas including Antitrust/Competition, M&A, Arbitration & Litigation, and Intellectual Property, by Chambers & Partners, ALB, Asialaw, Legal 500 and other renowned ranking institutions.
Headquartered in Beijing, we have opened branch offices in Shanghai and Shenzhen, and continue to growing rapidly, with more than 300 professionals and supporting staff currently working across our three offices. As successful practitioners in their fields, our lawyers continue to demonstrate excellence in their legal work and commitment to their profession. Most of our lawyers have practiced in leading international law firms and gained many years of experience before joining AnJie. Certain of them have worked in national ministries of the People’s Republic of China and in international organizations, and have built their careers while maintaining harmonious connections with various government bodies and international organizations.
Shanghai Beshining Law Office was founded in 2013 by main partner Xue Qi and his team from Shanghai Zhixin Patent Agent Ltd., and its headquarters is located in Shanghai. As one of the few leading law offices authorized to engage in patent and trademark, we currently house more than one hundred personnel including lawyers, patent attorneys, and other legal and technical professionals with diverse background and expertise. Our partners and their team have been providing nearly thousands of domestic and foreign enterprises with full intellectual property legal service and comprehensive domestic and foreign legal service of patent, trademark, copyright, integrated circuit layout design, anti-unfair competition and trade secret. The quantities of patent applications, trademark applications and lawsuits are all top rated nationwide. Especially, our team in Chemistry, Pharmaceuticals and Biology in which we have 16 lawyers and 36 patent attorneys is in the top tier of China, and our firm enjoys a patent grant rate of over 90% for invention in such areas. For three consecutive years (2015-2017), our team was awarded the title of Outstanding IP Service Team in China by China IP Magazine and China Daily IPR Channel.
LexOrbis is one of the most recommended full service IP firms in India with offices at 3 locations namely, New Delhi, Mumbai and Bangalore. We have a strong team of over 65 attorneys including 46 patent attorneys having expertise in the field of mechanical, electronics, wireless communication, software, mobile applications, chemistry, biotechnology, etc. who are involved in drafting new patent applications originating from India and filing and prosecuting international patent applications. A team of over 19 lawyers at our firm also have deep expertise in handling trademark prosecution and contentious cases. Our patent and trademark attorneys work in combination with our IP litigators to handle a large number contentious IP cases such as pre-and post- grant oppositions, cancellation and infringement suits and criminal enforcement of India rights in India.
Asia Pharma R&D Leaders Summit 2018  |  Telephone: +86 21 6172 6970  |  E-mail:
© 2017 Asia Pharma R&D Leaders Summit 2018- All rights reserved